https://scholars.lib.ntu.edu.tw/handle/123456789/568387
標題: | Hepatocellular carcinoma and hepatitis C virus | 作者: | Wang S.-H. Shiou-Hwei Yeh PEI-JER CHEN |
關鍵字: | Androgen receptor (AR); Chronic hepatitis C (CHC); Estrogen receptor α (ERα); Hepatitis C virus (HCV); Hepatocellular carcinoma (HCC); Sustained virologic response (SVR) | 公開日期: | 2016 | 出版社: | Springer Japan | 起(迄)頁: | 109-136 | 來源出版物: | Hepatitis C Virus II: Infection and Disease | 摘要: | Hepatocellular carcinoma (HCC) is an important health issue worldwide. It is a liver malignancy with heterogeneous etiologies. Among them, chronic hepatitis C virus (HCV) infection is one major cause. In chronically infected hepatocytes, HCV directly induces oxidative stress, impairs DNA damage response, manipulates cell cycle control and generates insulin resistance, possibly promoting DNA mutations accumulated in host genome from hepatitis stages in a long time. The predisposing polymorphisms or genetic mutations in critical proto-oncogenes and tumor suppressor genes, in synergy with epigenetic alterations after HCV invasion, would eventually transform hepatocytes to HCC tumor cells. Therefore, this chapter focuses on reviewing the virologic role of HCV in disease progression, as well as the host genetic changes for HCC development. Besides, the oncogenic mechanisms evoked by HCV at cellular level and the sex disparity of HCV-related HCC based on sex hormone effects are discussed individually. The comprehensive understanding of HCV-induced hepatocarcinogenesis paves the way to develop novel prophylactic or therapeutic strategies for HCC in future. ? 2016 Springer Japan. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018058361&doi=10.1007%2f978-4-431-56101-9_4&partnerID=40&md5=fe888ffaf00ce360ce61e9e652e9de68 https://scholars.lib.ntu.edu.tw/handle/123456789/568387 |
ISSN: | #VALUE! | DOI: | 10.1007/978-4-431-56101-9_4 |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。